AY vs SRRK Comparison

Atlantica Sustainable Infrastructure PLC owns, manages, and acquires renewable energy, conventional power, electric transmission lines and water assets. It is focused on North America (the United States and Mexico), South America (Peru, Chile, Brazil, and Uruguay) and EMEA (Spain, Algeria and South Africa). The company's segments include North America, South America and Europe, Middle East and Africa. The renewable energy sector includes the company's activities related to the production of electricity from solar power and wind plants. Atlantica derives the majority of its revenues from EMEA, followed by South America and North America.

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company operates in the United States. The company's product candidate is Apitegroma which is a selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.